Product logins

Find logins to all Clarivate products below.


Transcatheter Embolization and Occlusion Devices | Market Insights | Asia Pacific (Supplemental) | 2025

The Asia Pacific TEO device market will experience moderate growth through 2033. This growth will be driven by the introduction and rising adoption of new devices supported by favorable clinical data. Additionally, increased access to TEO devices and a growing demand for TEO procedures among an expanding patient population will contribute to this trend. Furthermore, the increasing disease burden and the availability of enhanced diagnostic techniques facilitating earlier and more accurate detection of conditions treatable with TEO devices will drive growth in the market. However, ongoing cost constraints in the region will continue to pose challenges for the market.

This Medtech 360 Report provides high-level market metrics for TEO devices in Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific from 2019 through 2033.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Vascular Closure Devices – Market Insights – Global
The global VCD market will grow moderately, driven primarily by increasing endovascular interventional procedure volumes and by innovation associated with new products entering the market. Growth…
Report
Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…